Latest filing published 08 Oct 2024 for MoonLake Immunotherapeutics, €8.3M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Simon Sturge: trading record in brief
This profile gathers the share dealings of Simon Sturge in MoonLake Immunotherapeutics. We count 3 filings; the first trade dates from 1 October 2023 and the latest from 4 October 2024.
Sales make up the whole of the open-market record (1 sale, €8.3M). 2024 to date brings no purchases and 1 sale.
On 8 October 2024 came the latest disclosure, an open-market sale for €8.3M in MoonLake Immunotherapeutics. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Simon Sturge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 171,000 shares@ US$53.72100.0% of flowClass A ordinary shares, par value $0.0001 per shareSEC:0001213900-24-086271:0
- 342,980 sharesClass C ordinary shares, par value $0.0001 per shareSEC:0001013762-23-001303:1
- 342,980 sharesClass A ordinary shares, par value $0.0001 per shareSEC:0001013762-23-001303:0
3 of 3 declarations
